Public Alert No. 11/2025 – Recall of Various Products by Sun Pharma, Glenmark, and Zydus Pharmaceuticals Over Manufacturing Issues
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public of the recall of various products by three drug manufacturing companies in the United States. According to recent information by the U.S. Food and Drug Administration (FDA), leading pharmaceutical firms in India, Glenmark Pharmaceuticals, Sun Pharmaceutical Industries, and Zydus, are recalling multiple drug products […]
Public Alert No. 010/2025 – Alert on the Sale of a Fake Product Named Wonder Calcium by Health and Hygiene
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing healthcare providers and the public about a report of the sale of a falsified product- Wonder Calcium with fake NAFDAC Registration Number 04-1029. NAFDAC received a complaint from Asad Pharmaceutical Ltd, reporting on the sale of a falsified product (Wonder Calcium). The […]
Public Alert No. 09/2025 – Voluntary Recall of Zovirax IV Infusion by GlaxoSmithKline (GSK) Limited Due to Potential Quality Defects
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying the public that GlaxoSmithKline (GSK) Limited has voluntarily recalled one lot of Zovirax IV Infusion 250mg RN3T in Hong Kong due to potential quality defects. The Department of Health (DH) Hong Kong received notification from GSK that its branch in Taiwan is […]
Press Briefing on the Regulatory Framework for Bioequivalence and it’s Relevance to the Nigerian Market
Bioequivalence (BE) is a critical scientific concept that ensures the quality, safety, and efficacy of generic drug products in comparison to their innovator counterparts. It establishes the interchangeability of generic medicines with their branded equivalents, relying on statistically significant clinical outcomes to confirm that generics deliver comparable therapeutic effects. Innovator drugs undergo rigorous phases of […]
Public Alert No. 08/2025 –Alert on the Presence of Counterfeit Artemether/Lumefantrine Tablets Circulating Under Brand Name Aflotin 20/120 in Nigeria
The National Agency for Food and Drug Administration and Control is notifying the public of the presence of one batch of counterfeit Artemether/Lumefantrine tablets circulating under the brand name Aflotin 20/120 in Nigeria. The counterfeit product was discovered and reported to the Agency by the genuine manufacturer, Ajanta Pharma Limited Mumbai, India, According to Ajanta […]
